Bank of America’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104 | Buy |
29
+2
| +7% | +$7 | ﹤0.01% | 6920 |
|
|
2025
Q1 | $59 | Hold |
27
| – | – | ﹤0.01% | 6887 |
|
|
2024
Q4 | $82 | Hold |
27
| – | – | ﹤0.01% | 6854 |
|
|
2024
Q3 | $62 | Hold |
27
| – | – | ﹤0.01% | 6868 |
|
|
2024
Q2 | $76 | Buy |
27
+10
| +59% | +$28 | ﹤0.01% | 6867 |
|
|
2024
Q1 | $75 | Sell |
17
-19
| -53% | -$84 | ﹤0.01% | 6520 |
|
|
2023
Q4 | $273 | Buy |
36
+19
| +112% | +$144 | ﹤0.01% | 6369 |
|
|
2023
Q3 | $122 | Buy |
+17
| New | +$122 | ﹤0.01% | 6527 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$18 | – | 6844 |
|
|
2023
Q1 | $18 | Sell |
1
-1
| -50% | -$18 | ﹤0.01% | 6743 |
|
|
2022
Q4 | $64 | Buy |
+2
| New | +$64 | ﹤0.01% | 6931 |
|
|
2022
Q3 | – | Sell |
-1,376
| Closed | -$124K | – | 7027 |
|
|
2022
Q2 | $124K | Sell |
1,376
-274
| -17% | -$24.7K | ﹤0.01% | 5594 |
|
|
2022
Q1 | $142K | Sell |
1,650
-1,316
| -44% | -$113K | ﹤0.01% | 5902 |
|
|
2021
Q4 | $272K | Buy |
2,966
+84
| +3% | +$7.7K | ﹤0.01% | 5517 |
|
|
2021
Q3 | $583K | Buy |
2,882
+2,613
| +971% | +$529K | ﹤0.01% | 4752 |
|
|
2021
Q2 | $125K | Buy |
+269
| New | +$125K | ﹤0.01% | 5608 |
|